60 likes | 64 Vues
The global research antibodies market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data. Rising research activities in the field of stem cells is a significant factor driving the growth of the market.
E N D
Research Antibodies Market To Reach USD 5.33 Billion By 2028 www.reportsanddata.com
Market Summary Market Size – USD 3.35 Billion in 2019, Market Growth - CAGR of 5.9%, Market Trends – Increased funding for research and development activities The global Research Antibodies Market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data. Rising research activities in the field of stem cells is a significant factor driving the growth of the market. Further key findings from the report suggest: By product, primary antibodies held a larger market share in 2019. Primary antibodies are those, which bind to the antigen, protein, or any substance that is intended to be studied. Primary antibodies, in immunoassays, are of prime importance to bind to the target antigen. By technology, western blotting contributed to the largest market share in 2019. The benefits of western blots comprise the capacity to detect picogram levels of protein in a sample, enabling it to be used for several applications such as an effective early diagnostic tool. Also, it lets researchers for direct labeling of primary antibodies, therefore removing the requirement of secondary antibodies. The market in the Asia Pacific region is expected to grow at the fastest rate of 7.1% in the forecast period. The high growth of the APAC region is owing to the growth of the pharmaceutical industry, surge in R&D activities for antibodies, and acceptance of innovative methods for antibody production, among others. www.reportsanddata.com
MarketSummary Key Players: Becton, Dickinson and Company, Lonza Group, Agilent Technologies, Abcam PLC, PerkinElmer, Inc., Bio-Rad Laboratories, Merck Millipore, F.Hoffmann-La Roche AG, Thermo Fisher Scientific, and Cell Signaling Technology Inc., among others. Segmentation: • Product Outlook (Revenue, USD Million; 2017-2027) • Primary Antibodies • Secondary Antibodies • Antibody Type Outlook (Revenue, USD Million; 2017-2027) • Monoclonal • Polyclonal • Technology Outlook (Revenue, USD Million; 2017-2027) • Western Blotting • Flow Cytometry • Immunofluorescence • Immunohistochemistry • Enzyme-linked Immunosorbent Assay • Immunoprecipitation www.reportsanddata.com Ask for Sample Report at: https://www.reportsanddata.com/sample-enquiry-form/3270
Market Summary • Application Outlook (Revenue, USD Million; 2017-2027) • Oncology • Infectious Diseases • Stem Cells • Neurobiology • Immunology • Others • Industry Vertical Outlook (Revenue, USD Million; 2017-2027) • Pharmaceutical & Biopharmaceutical • Academic & Research Institutes • Contract Research Organizations • Regional Outlook (Revenue, USD Billion; 2017-2027) • North America • Europe • Asia Pacific • MEA • Latin America www.reportsanddata.com Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3270
The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com
About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com www.reportsanddata.com